Please login to the form below

Not currently logged in
Email:
Password:

Varuby

This page shows the latest Varuby news and features for those working in and with pharma, biotech and healthcare.

J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use

Tesaro picked up a positive opinion for Varuby (rolapitant), an oral substance P/neurokinin-1 (NK-1) receptor antagonist for treating chemotherapy-induced nausea and vomiting, and Shire got the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics